|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| EXPENSES | |||||
| Amortization (Note 6) | |||||
| Officers and Directors fees (Note 8) | |||||
| Legal fees | |||||
| Office & general | |||||
| Patent consulting fees | |||||
| Professional fees & services | |||||
| Stock-based compensation (Note 11) | |||||
| Recovery of expenses previously paid | |||||
| Total expenses | |||||
| Gain on settlement of accrued payables (Note 8) | |||||
| OTHER INCOME | |||||
| Impairment on intangible assets (Note 6) | |||||
| Loss on settlement of litigation (Note 12, 14) | |||||
| Gain on settlement (Note 13) | |||||
| Gain on settlement of accounts payable (Note 12) | |||||
| Total other income | |||||
| LOSS AND COMPREHENSIVE LOSS FOR THE YEAR | |||||
| Basic loss per common share | |||||
| Diluted loss per common share | |||||
| Weighted-average number of common shares outstanding, basic | |||||
| Weighted-average number of common shares outstanding, diluted | |||||
Loading...
